Ticker
ABVCCompany Name
ABVC BIOPHARMA INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Earning Before Interest & Taxes (EBIT) | EBIT Margin | Revenues |
---|---|---|---|
6/30/2025 | $ -2.8M | -715.36% | $ 391.24K |
3/31/2025 | $ -1.56M | -306.53% | $ 508.38K |
12/31/2024 | $ -4.19M | -821.74% | $ 509.59K |
9/30/2024 | $ -5.91M | -1159.46% | $ 509.79K |
6/30/2024 | $ -8.04M | -5897.54% | $ 136.4K |
3/31/2024 | $ -9.25M | -36460.87% | $ 25.36K |
12/31/2023 | $ -7.77M | -5095% | $ 152.43K |
9/30/2023 | $ -9.7M | -1312.2% | $ 739.26K |
6/30/2023 | $ -11.17M | -1459.53% | $ 765.64K |
3/31/2023 | $ -11.03M | -1028.95% | $ 1.07M |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
EBIT / Revenues
(=) EBIT %
EBIT % for ABVC BIOPHARMA INC is calculated as follows: EBIT [ $ -11.79M ] / Revenues [ $ 355.8K ]
(=) EBIT % [ -3312.73% ]
Minimum
Mar 31, 2024
Maximum
Mar 31, 2025
Average
Median
filtered constituents | 3.26K |
---|---|
min | -73.16% |
max | 83.08% |
average | 9.55% |
median | 9.01% |
std | 23.96% |